B. Matija Peterlin

19.4k total citations · 2 hit papers
188 papers, 15.8k citations indexed

About

B. Matija Peterlin is a scholar working on Virology, Molecular Biology and Immunology. According to data from OpenAlex, B. Matija Peterlin has authored 188 papers receiving a total of 15.8k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Virology, 93 papers in Molecular Biology and 78 papers in Immunology. Recurrent topics in B. Matija Peterlin's work include HIV Research and Treatment (105 papers), Immune Cell Function and Interaction (50 papers) and HIV/AIDS drug development and treatment (47 papers). B. Matija Peterlin is often cited by papers focused on HIV Research and Treatment (105 papers), Immune Cell Function and Interaction (50 papers) and HIV/AIDS drug development and treatment (47 papers). B. Matija Peterlin collaborates with scholars based in United States, Slovenia and Germany. B. Matija Peterlin's co-authors include David H. Price, Koh Fujinaga, Paul A. Luciw, Matjaž Barborič, Katherine A. Jones, O. Fackler, Matthias Geyer, S. Kanazawa, Yong‐Hui Zheng and Ran Taube and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

B. Matija Peterlin

188 papers receiving 15.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Controlling the Elongation Phase of Transcription with P-TEFb

2006 874 citations B. Matija Peterlin, David H. Price Molecular Cell profile →
CONTROL OF RNA INITIATION AND ELONGATION AT THE HIV-1 PROMOTER

1994 538 citations B. Matija Peterlin et al. profile →

Peers

Countries citing papers authored by B. Matija Peterlin

Since Specialization

Citations

This map shows the geographic impact of B. Matija Peterlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Matija Peterlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Matija Peterlin more than expected).

Fields of papers citing papers by B. Matija Peterlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Matija Peterlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Matija Peterlin. The network helps show where B. Matija Peterlin may publish in the future.

Co-authorship network of co-authors of B. Matija Peterlin

This figure shows the co-authorship network connecting the top 25 collaborators of B. Matija Peterlin. A scholar is included among the top collaborators of B. Matija Peterlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Matija Peterlin. B. Matija Peterlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P-TEFb: The master regulator of transcription elongation 2023 ·Molecular Cell ·Koh Fujinaga, Fang Huang, B. Matija Peterlin	70
2	P-TEFb is degraded by Siah1/2 in quiescent cells 2022 ·Nucleic Acids Research ·Fang Huang, Yongmei Feng, B. Matija Peterlin, Koh Fujinaga	6
3	Proteasomal Inhibition Potentiates Latent HIV Reactivation 2020 ·AIDS Research and Human Retroviruses ·Daniele C. Cary, B. Matija Peterlin	4
4	HIV Transcription Is Independent of Mediator Kinases 2019 ·AIDS Research and Human Retroviruses ·Daniele C. Cary, (unknown), Ajda Rojc, B. Matija Peterlin	7
5	HEXIM1-Tat chimera inhibits HIV-1 replication 2018 ·PLoS Pathogens ·Marie Leoz, Petra Kukanja, Zeping Luo, Fang Huang, Daniele C. Cary, B. Matija Peterlin, Koh Fujinaga	17
6	Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors 2018 ·PLoS Pathogens ·Jennifer M. Binning, Amber M. Smith, Judd F. Hultquist, Charles S. Craik, (unknown), Melody G. Campbell, (unknown), (unknown), Michael McGregor, (unknown), Koen Bartholomeeusen, B. Matija Peterlin, Nevan J. Krogan, Natalia Sevillano, Yifan Cheng, John D. Gross	17
7	Natural Products and HIV/AIDS 2017 ·AIDS Research and Human Retroviruses ·Daniele C. Cary, B. Matija Peterlin	37
8	Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein 2012 ·Journal of Biological Chemistry ·Koen Bartholomeeusen, Yanhui Xiang, Koh Fujinaga, B. Matija Peterlin	154
9	APOBEC3 proteins and reverse transcription 2008 ·Virus Research ·Renato Santana Aguiar, B. Matija Peterlin	40
10	AIRE Recruits P-TEFb for Transcriptional Elongation of Target Genes in Medullary Thymic Epithelial Cells 2007 ·Molecular and Cellular Biology ·(unknown), (unknown), Jiří Kohoutek, Tomaž Vaupotič, Mojca Narat, B. Matija Peterlin	122
11	Controlling the Elongation Phase of Transcription with P-TEFb breakdown → 2006 ·Molecular Cell ·B. Matija Peterlin, David H. Price	874
12	Runx1 Binds Positive Transcription Elongation Factor b and Represses Transcriptional Elongation by RNA Polymerase II: Possible Mechanism of CD4 Silencing 2005 ·Molecular and Cellular Biology ·Huimin Jiang, Fan Zhang, (unknown), B. Matija Peterlin	41
13	Subunit H of the V-ATPase Binds to the Medium Chain of Adaptor Protein Complex 2 and Connects Nef to the Endocytic Machinery 2002 ·Journal of Biological Chemistry ·Matthias Geyer, (unknown), Robert Mandić, Thomas Linnemann, Yong‐Hui Zheng, O. Fackler, B. Matija Peterlin	84
14	Interactions between Tat and TAR and Human Immunodeficiency Virus Replication Are Facilitated by Human Cyclin T1 but Not Cyclins T2a or T2b 1999 ·Virology ·(unknown), Koh Fujinaga, Ran Taube, Thomas P. Cujec, Yuerong Zhu, Junmin Peng, David H. Price, B. Matija Peterlin	71
15	Interactions between HIV1 Nef and Vacuolar ATPase Facilitate the Internalization of CD4 1998 ·Immunity ·Xiaobin Lü, Haifeng Yu, Shu‐Hui Liu, Frances M. Brodsky, B. Matija Peterlin	218
16	The N-Terminus of Nef from HIV-1/SIV Associates with a Protein Complex Containing Lck and a Serine Kinase 1997 ·Immunity ·Andreas S. Baur, Gabriele Sass, Bernd Laffert, Dieter Willbold, Cecilia Cheng‐Mayer, B. Matija Peterlin	145
17	Binding and cooperative interactions between two B cell-specific transcriptional coactivators. 1996 ·The Journal of Experimental Medicine ·Joseph D. Fontes, Nabila Jabrane‐Ferrat, (unknown), B. Matija Peterlin	43
18	Second Exon of Tat of HIV-2 Is Required for Optimal Trans-Activation of HIV-1 and HIV-2 LTRs 1993 ·Virology ·Sandra Tong-Starksen, Andreas S. Baur, (unknown), (unknown), B. Matija Peterlin	22
19	B-Cell Factor 1 Is Required for Optimal Expression of the DRA Promoter in B Cells 1992 ·Molecular and Cellular Biology ·Charles F. Voliva, Ami Aronheim, Michael Walker, B. Matija Peterlin	20
20	Mutational Analysis of the DRA Promoter: cis- Acting Sequences and trans -Acting Factors 1990 ·Molecular and Cellular Biology ·Sue Y. Tsang, Mikiye Nakanishi, B. Matija Peterlin	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact